These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 426513)

  • 1. Treatment of experimental Staphylococcus aureus abscesses: comparison of cefazolin, cephalothin, cefoxitin, and cefamandole.
    Kaye D; Parsons JN; Carrizosa J; Kobasa WD
    Antimicrob Agents Chemother; 1979 Feb; 15(2):200-3. PubMed ID: 426513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin.
    Carrizosa J; Santoro J; Kaye D
    Antimicrob Agents Chemother; 1978 Jan; 13(1):74-7. PubMed ID: 626493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of single doses of cefazolin and cefamandole to penetrate experimental chronic Escherichia coli abdominal abscesses.
    Gerding DN; Kozak AJ; Peterson LR; Hall WH
    Antimicrob Agents Chemother; 1980 Jun; 17(6):1023-9. PubMed ID: 6996611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Lactamase-mediated inactivation and efficacy of cefazolin and cefmetazole in Staphylococcus aureus abscesses.
    Fields MT; Herndon BL; Bamberger DM
    Antimicrob Agents Chemother; 1993 Feb; 37(2):203-6. PubMed ID: 8452349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefoperazone treatment of experimental endocarditis.
    Snepar RA; Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1981 May; 19(5):773-6. PubMed ID: 6457556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of cefamandole and cephalothin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Wilson KJ
    J Bone Joint Surg Am; 1983 Apr; 65(4):507-13. PubMed ID: 6833327
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.
    Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1980 Oct; 18(4):562-5. PubMed ID: 7447418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation.
    Chapman SW; Steigbigel RT
    J Infect Dis; 1983 Jun; 147(6):1078-89. PubMed ID: 6602190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing.
    Bamberger DM; Fields MT; Herndon BL
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2335-9. PubMed ID: 1804006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diffusion of cefotaxime in the interstitial fluid of rabbits. Comparison with cefazolin, cefoxitin and cefamandole (author's transl)].
    Boussougant Y; Contrepois A; Doquir C; Carbon C
    Nouv Presse Med; 1981 Feb; 10(8):591-3. PubMed ID: 6259599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.
    Goldman PL; Petersdorf RG
    J Infect Dis; 1980 Mar; 141(3):331-7. PubMed ID: 6965978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for experimental intraabdominal sepsis: comparison of four cephalosporins with clindamycin plus gentamicin.
    Louie TJ; Onderdonk AB; Gorbach SL; Bartlett JG
    J Infect Dis; 1977 Mar; 135 Suppl():S18-22. PubMed ID: 321707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections.
    Kernodle DS; Classen DC; Burke JP; Kaiser AB
    JAMA; 1990 Feb; 263(7):961-6. PubMed ID: 2299764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefazolin versus cephalothin in beta-lactamase-producing Staphylococcus aureus endocarditis in a rabbit experimental model.
    Carrizosa J; Kobasa WD; Snepar R; Kaye KM; Kaye D
    J Antimicrob Chemother; 1982 May; 9(5):387-93. PubMed ID: 6980218
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV; Sanders CC; Sanders W
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of cephalosporins by Bacteroides.
    Tally FP; O'Keefe JP; Sullivan NM; Gorbach SL
    Antimicrob Agents Chemother; 1979 Nov; 16(5):565-71. PubMed ID: 525995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
    Oguz H; Ozbilge H; Oguz E; Gurkan T
    Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of ten cephalosporins on biomass of methicillin-susceptible and -resistant Staphylococcus aureus.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F
    Antimicrob Agents Chemother; 1980 May; 17(5):856-60. PubMed ID: 6901595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK; Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae.
    Phillips I; Shannon K
    Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.